4Elmers L,Knowles J.Ventricular expression of atrial and brain natriuretic peptide in NPR-1 deficientmice with cardiac hypertrophy and fibrosis.Am J Physiol,2002,283:707-714.
5Vicky AC,Leigh J.M inireview,Natriuretic peptides during development of the fetal heart and circulation.Endocrinology,2003,144(6):2191-2194.
6Surakit Nathisuwan,Robert L,Talbert A.Review of vasopeptidase inhibitors a new modality in the treament of hypertension and chronic heart failure.Pharmacotherapy,2002,22(1):27-42.
7Miriam TR,Richard AM.Cardiac natriuretic peptides for cardiac health.Clinical Science,2005,108:23-36.
8Osman R,Alat I,Coskun S,et al.The role of brain natriuretic peptide in the prediction of cardiac performace in coronary artery bypass grafting.Tex Heart Inst J,2003,30:298-304.
9James A,Lemos MD,David A.Morrow MD.Brain natriuretic peptide measurement in actue coronary syndrome:Ready for clinical application.Circulation,2002,106:2868-2870.
10Roberto L,Serge M,Inder A,et al.Efects of valsartan on circulating brain natriuretic peptide an norepingphrine in symptomatic chronic heart failure.Circulation,2002,106(19):2454-2458.
1Abraham WT,Cheng ML,Smoluk G,et al.Clinical and hemodynamiceffects of nesiritide(B-type natriuretic peptide)in patients withdecompensated heart failure receiving beta blockers[J].Congest HeartFail,2005,11⑵:59-64.
2Michaels AD,Klein A5Madden JA,et a I.Effects of intravenousnesiritide on human coronary vasomotor regulation and myocardialoxygen uptake[J].C irculation,2003,107:2697-2701.
3Souzal SPDiYellon DM5Martin C,et al.B-type natriuretie pep tidelimits infarct size in rat isolated hearts via KATP channel opening[J].Am J Physiol Heart Circ Physiol,2003,284:1592-1600.
